APTO - Aptose Biosciences Q2 2022 Earnings Preview
- Aptose Biosciences ( NASDAQ: APTO ) is scheduled to announce Q2 earnings results on Monday, August 1st, after market close.
- The consensus EPS Estimate is -$0.13 and the consensus Revenue Estimate is $0M
- Over the last 3 months, EPS estimates have seen 6 upward revisions and 0 downward.
For further details see:
Aptose Biosciences Q2 2022 Earnings Preview